Antithrombin deficiency, whether inherited or acquired, poses a significant risk factor for venous thromboembolism (VTE) by impairing the natural regulation of coagulation. As a critical plasma ...
ST. LOUIS -- Alireza "Ray" Rezaie, Ph.D., professor of biochemistry and molecular biology at Saint Louis University School of Medicine, has received a $1.52 million NIH grant to study how the key ...
A striking clinical feature of illness from SARS-CoV-2 is a marked increase in thrombotic and microvascular complications, or COVID-19–associated coagulopathy (CAC). A new study suggests endothelial ...
ATryn Available for Patients with Hereditary Antithrombin Deficiency, a Rare Blood Clotting Disorder
DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck Inc., a wholly owned subsidiary of H. Lundbeck A/S in Denmark (LUN: Copenhagen Stock Exchange), announced today that ATryn ® (Antithrombin [Recombinant]) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results